{"id":"https://openalex.org/W2551991877","doi":"https://doi.org/10.1080/09546634.2016.1254145","title":"The effect of tumor necrosis factor inhibitor therapy on the incidence of myocardial infarction in patients with psoriasis: a retrospective study","display_name":"The effect of tumor necrosis factor inhibitor therapy on the incidence of myocardial infarction in patients with psoriasis: a retrospective study","publication_year":2016,"publication_date":"2016-11-24","ids":{"openalex":"https://openalex.org/W2551991877","doi":"https://doi.org/10.1080/09546634.2016.1254145","mag":"2551991877","pmid":"https://pubmed.ncbi.nlm.nih.gov/27881030"},"language":"en","primary_location":{"id":"doi:10.1080/09546634.2016.1254145","doi":"https://doi.org/10.1080/09546634.2016.1254145","is_oa":true,"landing_page_url":"https://doi.org/10.1080/09546634.2016.1254145","pdf_url":"https://www.tandfonline.com/doi/pdf/10.1080/09546634.2016.1254145?needAccess=true","source":{"id":"https://openalex.org/S21432770","display_name":"Journal of Dermatological Treatment","issn_l":"0954-6634","issn":["0954-6634","1471-1753"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320449","host_organization_name":"Informa","host_organization_lineage":["https://openalex.org/P4310320449"],"host_organization_lineage_names":["Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Dermatological Treatment","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://www.tandfonline.com/doi/pdf/10.1080/09546634.2016.1254145?needAccess=true","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5019413230","display_name":"Dalia Mahmoud Kamel Shaaban","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I21376657","display_name":"Tanta University","ror":"https://ror.org/016jp5b92","country_code":"EG","type":"education","lineage":["https://openalex.org/I21376657"]}],"countries":["EG"],"is_corresponding":false,"raw_author_name":"Dalia Shaaban","raw_affiliation_strings":["Department of Dermatology and Venereology, Tanta University","Department of Dermatology and Venereology, Tanta University, Tanta, Egypt;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Dermatology and Venereology, Tanta University","institution_ids":["https://openalex.org/I21376657"]},{"raw_affiliation_string":"Department of Dermatology and Venereology, Tanta University, Tanta, Egypt;","institution_ids":["https://openalex.org/I21376657"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5111496725","display_name":"Nawaf Al-Mutairi","orcid":"https://orcid.org/0009-0002-7173-4514","observed_orcids":["https://orcid.org/0009-0002-7173-4514"]},"institutions":[{"id":"https://openalex.org/I36721946","display_name":"Kuwait University","ror":"https://ror.org/021e5j056","country_code":"KW","type":"education","lineage":["https://openalex.org/I36721946"]}],"countries":["KW"],"is_corresponding":true,"raw_author_name":"Nawaf Al-Mutairi","raw_affiliation_strings":["Department of Dermatology, Kuwait University","Department of Dermatology, Kuwait University, Farwaniya, Kuwait"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Dermatology, Kuwait University","institution_ids":["https://openalex.org/I36721946"]},{"raw_affiliation_string":"Department of Dermatology, Kuwait University, Farwaniya, Kuwait","institution_ids":["https://openalex.org/I36721946"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5111496725"],"corresponding_institution_ids":["https://openalex.org/I36721946"],"apc_list":null,"apc_paid":null,"fwci":0.9656,"has_fulltext":true,"cited_by_count":18,"citation_normalized_percentile":{"value":0.74199894,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":97},"biblio":{"volume":"29","issue":"1","first_page":"3","last_page":"7"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10469","display_name":"Psoriasis: Treatment and Pathogenesis","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10469","display_name":"Psoriasis: Treatment and Pathogenesis","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11092","display_name":"Spondyloarthritis Studies and Treatments","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10200","display_name":"Rheumatoid Arthritis Research and Therapies","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/psoriasis","display_name":"psoriasis","score":0.9490000009536743},{"id":"https://openalex.org/keywords/tumor-necrosis-factor-inhibitors","display_name":"tumor necrosis factor inhibitors","score":0.9430000185966492},{"id":"https://openalex.org/keywords/myocardial-infarction","display_name":"myocardial infarction","score":0.9980000257492065},{"id":"https://openalex.org/keywords/methotrexate","display_name":"methotrexate","score":0.9049999713897705},{"id":"https://openalex.org/keywords/topical-therapy","display_name":"topical treatment","score":0.7269999980926514},{"id":"https://openalex.org/keywords/cardiovascular-risk","display_name":"cardiovascular risk","score":0.953000009059906},{"id":"https://openalex.org/keywords/treatment-response","display_name":"treatment response","score":0.8450000286102295},{"id":"https://openalex.org/keywords/inflammatory-skin-diseases","display_name":"inflammatory skin diseases","score":0.3580000102519989}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9578923583030701},{"id":"https://openalex.org/C2780564577","wikidata":"https://www.wikidata.org/wiki/Q179945","display_name":"Psoriasis","level":2,"score":0.9507325887680054},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6880984902381897},{"id":"https://openalex.org/C500558357","wikidata":"https://www.wikidata.org/wiki/Q12152","display_name":"Myocardial infarction","level":2,"score":0.6416172981262207},{"id":"https://openalex.org/C2781059491","wikidata":"https://www.wikidata.org/wiki/Q422232","display_name":"Methotrexate","level":2,"score":0.6130555868148804},{"id":"https://openalex.org/C17991360","wikidata":"https://www.wikidata.org/wiki/Q21173843","display_name":"Tumor necrosis factor alpha","level":2,"score":0.6032673716545105},{"id":"https://openalex.org/C2779722408","wikidata":"https://www.wikidata.org/wiki/Q1536078","display_name":"TNF inhibitor","level":4,"score":0.5973702669143677},{"id":"https://openalex.org/C61511704","wikidata":"https://www.wikidata.org/wiki/Q1671857","display_name":"Incidence (geometry)","level":2,"score":0.5608331561088562},{"id":"https://openalex.org/C167135981","wikidata":"https://www.wikidata.org/wiki/Q2146302","display_name":"Retrospective cohort study","level":2,"score":0.4795677065849304},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.4496791362762451},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.43646159768104553},{"id":"https://openalex.org/C50440223","wikidata":"https://www.wikidata.org/wiki/Q1475848","display_name":"Risk factor","level":2,"score":0.41627538204193115},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.3522951602935791},{"id":"https://openalex.org/C16005928","wikidata":"https://www.wikidata.org/wiki/Q171171","display_name":"Dermatology","level":1,"score":0.2636566162109375},{"id":"https://openalex.org/C2777138892","wikidata":"https://www.wikidata.org/wiki/Q415264","display_name":"Infliximab","level":3,"score":0.17179447412490845},{"id":"https://openalex.org/C120665830","wikidata":"https://www.wikidata.org/wiki/Q14620","display_name":"Optics","level":1,"score":0.0},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000068800","descriptor_name":"Etanercept","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000068800","descriptor_name":"Etanercept","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000068879","descriptor_name":"Adalimumab","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000068879","descriptor_name":"Adalimumab","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000069285","descriptor_name":"Infliximab","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000069285","descriptor_name":"Infliximab","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000287","descriptor_name":"Administration, Topical","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003879","descriptor_name":"Dermatologic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D003879","descriptor_name":"Dermatologic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008727","descriptor_name":"Methotrexate","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009203","descriptor_name":"Myocardial Infarction","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":false},{"descriptor_ui":"D009203","descriptor_name":"Myocardial Infarction","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":true},{"descriptor_ui":"D011565","descriptor_name":"Psoriasis","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D011565","descriptor_name":"Psoriasis","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D012189","descriptor_name":"Retrospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012306","descriptor_name":"Risk","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014409","descriptor_name":"Tumor Necrosis Factor-alpha","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D014409","descriptor_name":"Tumor Necrosis Factor-alpha","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D015994","descriptor_name":"Incidence","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1080/09546634.2016.1254145","doi":"https://doi.org/10.1080/09546634.2016.1254145","is_oa":true,"landing_page_url":"https://doi.org/10.1080/09546634.2016.1254145","pdf_url":"https://www.tandfonline.com/doi/pdf/10.1080/09546634.2016.1254145?needAccess=true","source":{"id":"https://openalex.org/S21432770","display_name":"Journal of Dermatological Treatment","issn_l":"0954-6634","issn":["0954-6634","1471-1753"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320449","host_organization_name":"Informa","host_organization_lineage":["https://openalex.org/P4310320449"],"host_organization_lineage_names":["Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Dermatological Treatment","raw_type":"journal-article"},{"id":"pmid:27881030","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/27881030","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of dermatological treatment","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1080/09546634.2016.1254145","doi":"https://doi.org/10.1080/09546634.2016.1254145","is_oa":true,"landing_page_url":"https://doi.org/10.1080/09546634.2016.1254145","pdf_url":"https://www.tandfonline.com/doi/pdf/10.1080/09546634.2016.1254145?needAccess=true","source":{"id":"https://openalex.org/S21432770","display_name":"Journal of Dermatological Treatment","issn_l":"0954-6634","issn":["0954-6634","1471-1753"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320449","host_organization_name":"Informa","host_organization_lineage":["https://openalex.org/P4310320449"],"host_organization_lineage_names":["Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Dermatological Treatment","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2551991877.pdf","grobid_xml":"https://content.openalex.org/works/W2551991877.grobid-xml"},"referenced_works_count":38,"referenced_works":["https://openalex.org/W1578324249","https://openalex.org/W1891655359","https://openalex.org/W1922126355","https://openalex.org/W1969097286","https://openalex.org/W1970059868","https://openalex.org/W1975162362","https://openalex.org/W1987593086","https://openalex.org/W1990882766","https://openalex.org/W2018950002","https://openalex.org/W2021018799","https://openalex.org/W2022665587","https://openalex.org/W2028621745","https://openalex.org/W2044465471","https://openalex.org/W2053200285","https://openalex.org/W2056468769","https://openalex.org/W2058733732","https://openalex.org/W2062864086","https://openalex.org/W2066963386","https://openalex.org/W2069936148","https://openalex.org/W2072781226","https://openalex.org/W2076355399","https://openalex.org/W2085498159","https://openalex.org/W2087722290","https://openalex.org/W2093116261","https://openalex.org/W2093839873","https://openalex.org/W2094941678","https://openalex.org/W2095652983","https://openalex.org/W2096809109","https://openalex.org/W2122865429","https://openalex.org/W2128340413","https://openalex.org/W2129939636","https://openalex.org/W2131872763","https://openalex.org/W2137499656","https://openalex.org/W2138399160","https://openalex.org/W2148378054","https://openalex.org/W2156593520","https://openalex.org/W2158723251","https://openalex.org/W2169773326"],"related_works":["https://openalex.org/W2044465471","https://openalex.org/W2091627092","https://openalex.org/W7098741816","https://openalex.org/W2409219374","https://openalex.org/W2440713342","https://openalex.org/W4238920061","https://openalex.org/W7096628551","https://openalex.org/W4232025424","https://openalex.org/W2076790550","https://openalex.org/W2079938037"],"abstract_inverted_index":{"BACKGROUND:":[0],"Psoriasis":[1],"has":[2],"been":[3],"shown":[4],"to":[5,75,176],"be":[6],"associated":[7],"with":[8,49,109,142,165,173,187],"increased":[9],"incidence":[10],"of":[11,20,37,43,65,106,133,150,162],"myocardial":[12],"infarction":[13],"(MI).":[14],"The":[15,89,131,148],"data":[16],"on":[17,26,40],"the":[18,35,41,60,160],"effect":[19,36],"tumor":[21],"necrosis":[22],"factor":[23],"(TNF)":[24],"inhibitors":[25,39,152],"MI":[27,44,107,120,134,163,184],"in":[28,45,119,137,153,159,183],"psoriasis":[29,46,69,93,154],"are":[30],"scarce.":[31],"OBJECTIVE:":[32],"To":[33],"evaluate":[34],"TNF":[38,82,96,123,138,151,177],"risk":[42,161],"patients":[47,70],"compared":[48,108,141,164,172,186],"methotrexate":[50],"(MTX)":[51],"and":[52,85,98,125,168],"topical":[53,86,110,166],"agents.":[54],"METHODS:":[55],"Data":[56],"were":[57,79],"obtained":[58],"from":[59,68,72],"Electronic":[61],"Health":[62],"Records":[63],"database":[64],"Farwaniya":[66],"Hospital":[67],"seen":[71],"January":[73],"2008":[74],"December":[76],"2014.":[77],"Patients":[78],"categorized":[80],"into":[81],"inhibitor,":[83],"MTX":[84,99,126],"cohorts.":[87],"RESULTS:":[88],"study":[90],"included":[91],"4762":[92],"patients.":[94],"Both":[95],"inhibitor":[97,124,139,178],"cohorts":[100,127],"showed":[101,155,180],"a":[102,156,169,181],"statistically":[103,116],"lower":[104,136],"rate":[105,121,185],"cohort.":[111],"However,":[112],"there":[113],"was":[114,135],"no":[115],"significant":[117,157],"difference":[118],"between":[122],"(P":[128],"=":[129,145],".32).":[130],"probability":[132],"responders":[140],"non-responders":[143],"(p":[144],".001).":[146],"CONCLUSIONS:":[147],"use":[149],"reduction":[158,171,182],"agents":[167],"non-significant":[170],"MTX.":[174],"Responders":[175],"therapy":[179],"non-responders.":[188]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":2},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":1}],"updated_date":"2026-11-03T10:50:19.383937","created_date":"2016-11-30T00:00:00"}